National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

10.6 Major clinical issues with somatoform disorders and stimulant (including methamphetamine) use

prev pageTOC |next page

Table of contents

10.6.1 Effects of stimulants on somatoform disorders

10.6.2 Interactions between stimulants and therapeutic agents for somatoform disorders

10.6.3 Management approaches to comorbid somatoform disorders and stimulant use

prev pageTOC |next page